Virginia Retirement Systems ET AL raised its stake in Steris PLC (NYSE:STE) by 33.8% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,200 shares of the medical equipment provider’s stock after buying an additional 5,100 shares during the period. Virginia Retirement Systems ET AL’s holdings in Steris were worth $2,586,000 at the end of the most recent quarter.
A number of other institutional investors also recently modified their holdings of STE. Bank of New York Mellon Corp raised its holdings in shares of Steris by 1.1% in the third quarter. Bank of New York Mellon Corp now owns 1,040,826 shares of the medical equipment provider’s stock worth $119,070,000 after acquiring an additional 10,838 shares during the last quarter. Martingale Asset Management L P raised its holdings in shares of Steris by 41.4% in the third quarter. Martingale Asset Management L P now owns 34,864 shares of the medical equipment provider’s stock worth $3,989,000 after acquiring an additional 10,205 shares during the last quarter. AQR Capital Management LLC raised its holdings in shares of Steris by 207.3% in the third quarter. AQR Capital Management LLC now owns 42,006 shares of the medical equipment provider’s stock worth $4,791,000 after acquiring an additional 28,337 shares during the last quarter. Neuberger Berman Group LLC raised its holdings in shares of Steris by 10.5% in the third quarter. Neuberger Berman Group LLC now owns 27,140 shares of the medical equipment provider’s stock worth $3,104,000 after acquiring an additional 2,581 shares during the last quarter. Finally, Nordea Investment Management AB acquired a new position in shares of Steris in the third quarter worth $4,653,000. Hedge funds and other institutional investors own 86.81% of the company’s stock.
In other Steris news, Director Mohsen Sohi sold 3,133 shares of the company’s stock in a transaction dated Tuesday, May 21st. The stock was sold at an average price of $135.94, for a total transaction of $425,900.02. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Michael B. Wood sold 3,609 shares of the company’s stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $121.79, for a total value of $439,540.11. The disclosure for this sale can be found here. Insiders sold 60,351 shares of company stock valued at $7,592,622 over the last quarter. Insiders own 2.38% of the company’s stock.
Steris stock traded up $0.31 during trading on Wednesday, hitting $136.11. The company’s stock had a trading volume of 440,347 shares, compared to its average volume of 432,194. The firm has a market capitalization of $11.57 billion, a P/E ratio of 27.83 and a beta of 1.06. Steris PLC has a 1-year low of $99.14 and a 1-year high of $137.60. The company has a current ratio of 2.27, a quick ratio of 1.99 and a debt-to-equity ratio of 0.37.
Steris (NYSE:STE) last released its earnings results on Monday, May 13th. The medical equipment provider reported $1.53 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.44 by $0.09. The firm had revenue of $768.00 million during the quarter, compared to analyst estimates of $738.87 million. Steris had a return on equity of 13.34% and a net margin of 10.93%. The business’s quarterly revenue was up 7.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.24 earnings per share. As a group, equities analysts predict that Steris PLC will post 5.38 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Wednesday, June 12th will be paid a $0.34 dividend. The ex-dividend date is Tuesday, June 11th. This represents a $1.36 annualized dividend and a yield of 1.00%. Steris’s payout ratio is currently 27.81%.
A number of equities analysts have recently weighed in on the company. JMP Securities boosted their price target on Steris from $135.00 to $150.00 and gave the stock a “market outperform” rating in a report on Wednesday. Stephens boosted their price target on Steris from $135.00 to $150.00 and gave the stock an “overweight” rating in a report on Wednesday, May 15th. KeyCorp boosted their price target on Steris from $135.00 to $138.00 and gave the stock an “overweight” rating in a report on Wednesday, May 15th. Finally, Zacks Investment Research raised Steris from a “hold” rating to a “buy” rating and set a $146.00 price target for the company in a report on Tuesday, April 30th. Five research analysts have rated the stock with a buy rating, The company has a consensus rating of “Buy” and an average target price of $148.20.
Steris Company Profile
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Featured Story: How to interpret a stock’s beta number
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.